Predictive Value of Dynamic Combination of BNP and NGAL for the Prognosis of Patients With Sepsis
Not Applicable
Completed
- Conditions
- 28-day MortalitySepsis
- Interventions
- Other: BNP and NGAL
- Registration Number
- NCT02871544
- Lead Sponsor
- Southeast University, China
- Brief Summary
Objective: to clarify the predictive value of brain natriuretic peptide (BNP) in combination with neutrophil gelatinase associated lipocalin (NGAL) for the prognosis of patients with sepsis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 124
Inclusion Criteria
- age ≥18 years and <85 years;
- presence of severe sepsis according to Survival Sepsis Campaign 10;
- all patients voluntarily joined this study with informed consents.
Exclusion Criteria
- participated in other trials within 30 days before the criteria for this trial were met;
- expected to die within 24 hours;
- pregnant;
- advanced malignancy with life expectancy <6 months;
- history of congestive heart failure;
- chronic renal dysfunction (baseline creatinine >176.8μmol/L); and
- relatives were unwilling to agree to the use of full life support.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Low BNP and High NGAL Group BNP and NGAL BNP≤100pg/ml and NGAL\>153pg/ml Low BNP and Low NGAL Group BNP and NGAL BNP≤100pg/ml and NGAL≤153pg/ml High BNP and Low NGAL Group BNP and NGAL BNP\>100pg/ml and NGAL≤153pg/ml High BNP and High NGAL Group BNP and NGAL BNP\>100pg/ml and NGAL\>153pg/ml
- Primary Outcome Measures
Name Time Method patient-ventilator synchrony for 30mins 30mins after the patients involved
- Secondary Outcome Measures
Name Time Method 28-day mortality 28 days after the patients involved Mechanical ventilation duration between day 1 and day 28 days of mechanical ventilation between day 1 and day 28 the numbers of days in the ICU between day 1 and day 28 the numbers of days in the ICU until day 28